Skip to main content

Advertisement

Log in

Actual drug–drug interactions in elderly patients discharged from internal medicine clinic: a prospective observational study

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

The aim of the study was to evaluate the incidence and type of actual drug–drug interactions (DDIs) that result in adverse drug reactions (ADRs) or diminished therapeutic effect in elderly patients within 30 days of discharge from an internal medicine clinic.

Methods

A prospective observational study was conducted at the Internal Medicine Clinic of University Hospital Dubrava, Zagreb, Croatia, between October and December 2011. Patients aged ≥65 years discharged from the Internal Medicine Clinic during the study period with a prescription for two or more medications were eligible for inclusion in the study. A total of 222 patients were ultimately enrolled in the study. For each patient, potential DDIs were identified using Lexi-Interact software. The follow-up visit was scheduled approximately 30 days after discharge. Causality between DDIs and ADRs or diminished therapeutic effect of drugs was assessed by two independent clinicians.

Results

Potential DDIs were identified in 190 (85.6 %) patients. Actual DDIs were detected in 21 (9.5 %) patients. In 19 patients, DDIs resulted in an ADR. Diminished therapeutic effect resulting from DDIs was detected in two patients. Angiotensin-converting enzyme inhibitors were the drug class most frequently associated with DDI-related ADRs.

Conclusions

A significant incidence of actual DDIs suggests that DDIs play an important role in patient safety. Drug therapy should be initiated if absolutely necessary, and the number of drugs used to treat elderly patients should be minimized to reduce the incidence of DDI-related adverse patient outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hartshorn EA (2006) Drug interaction: 1. General considerations. Ann Pharmacother 40:116–118

    Article  PubMed  Google Scholar 

  2. Hines LE, Murphy JE (2011) Potentially harmful drug–drug interactions in the elderly: a review. Am J Geriatr Pharmacother 9:364–377. doi:10.1016/j.amjopharm.2011.10.004

    Article  PubMed  CAS  Google Scholar 

  3. Mallet L, Spinewine A, Huang A (2007) The challenge of managing drug interactions in elderly people. Lancet 370:185–191

    Article  PubMed  CAS  Google Scholar 

  4. Delafuente JC (2003) Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol 48:133–143

    Article  PubMed  Google Scholar 

  5. Björkman IK, Fastbom J, Schmidt IK, Bernsten CB, Pharmaceutical Care of the Elderly in Europe Research (PEER) Group (2002) Drug–drug interactions in the elderly. Ann Pharmacother 36:1675–1681

    Article  PubMed  Google Scholar 

  6. Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BH (2007) Hospitalisations and emergency department visits due to drug–drug interactions: a literature review. Pharmacoepidemiol Drug Saf 16:641–651

    Article  PubMed  Google Scholar 

  7. Becker ML, Visser LE, van Gelder T, Hofman A, Stricker BH (2008) Increasing exposure to drug–drug interactions between 1992 and 2005 in people aged ≥55 years. Drugs Aging 25:145–152

    Article  PubMed  Google Scholar 

  8. Magro L, Moretti U, Leone R (2012) Epidemiology and characteristics of adverse drug reactions caused by drug–drug interactions. Expert Opin Drug Saf 11:83–94

    Article  PubMed  CAS  Google Scholar 

  9. Mirosevic Skvrce N, Macolic Sarinic V, Mucalo I, Krnic D, Bozina N, Tomic S (2011) Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study. Croat Med J 52:604–614

    Article  PubMed  Google Scholar 

  10. Seymour RM, Routledge PA (1998) Important drug–drug interactions in the elderly. Drugs Aging 12:485–494

    Article  PubMed  CAS  Google Scholar 

  11. Gagne JJ, Maio V, Rabinowitz C (2008) Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy. J Clin Pharm Ther 33:141–151

    Article  PubMed  CAS  Google Scholar 

  12. Lexi-Comp Online (2012) Lexi-Interact. Wolters Kluwer Health Clinical Solutions, Minneapolis. Available at: http://online.lexi.com/lco/action/interact. Accessed 3 Aug 2012

  13. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239–245

    Article  PubMed  CAS  Google Scholar 

  14. Macedo AF, Marques FB, Ribeiro CF, Teixeira F (2003) Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability. J Clin Pharm Ther 28:137–143

    Article  PubMed  CAS  Google Scholar 

  15. Forster AJ, Clark HD, Menard A, Dupuis N, Chernish R, Chandok N, Khan A, van Walraven C (2004) Adverse events among medical patients after discharge from hospital. Can Med Assoc J 170:345–349

    Google Scholar 

  16. Köhler GI, Bode-Böger SM, Busse R, Hoopmann M, Welte T, Böger RH (2000) Drug–drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther 38:504–513

    PubMed  Google Scholar 

  17. Bertoli R, Bissig M, Caronzolo D, Odorico M, Pons M, Bernasconi E (2010) Assessment of potential drug–drug interactions at hospital discharge. Swiss Med Wkly 140:w13043. doi:10.4414/smw.2010.13043

    PubMed  Google Scholar 

  18. Glintborg B, Andersen SE, Dalhoff K (2005) Drug-drug interactions among recently hospitalised patients—frequent but mostly clinically insignificant. Eur J Clin Pharmacol 61:675–681

    Article  PubMed  Google Scholar 

  19. Obreli Neto PR, Nobili A, Marusic S, Pilger D, Guidoni CM, Baldoni Ade O, Cruciol-Souza JM, Da Cruz AN, Gaeti WP, Cuman RK (2012) Prevalence and predictors of potential drug–drug interactions in the elderly: a cross-sectional study in the Brazilian primary public health system. J Pharm Pharm Sci 15:344–354

    PubMed  CAS  Google Scholar 

  20. Astrand B, Astrand E, Antonov K, Petersson G (2006) Detection of potential drug interactions—a model for a national pharmacy register. Eur J Clin Pharmacol 62:749–756

    Article  PubMed  Google Scholar 

  21. Obreli-Neto PR, Nobili A, De Lyra Júnior DP, Pilger D, Guidoni CM, Baldoni Ade O, Cruciol-Souza JM, Freitas AL, Tettamanti M, Gaeti WP, Cuman RK (2012) Incidence and predictors of adverse drug reactions caused by drug–drug interactions in elderly outpatients: a prospective cohort study. J Pharm Pharm Sci 15:344–354

    PubMed  CAS  Google Scholar 

  22. Glassman PA, Belperio P, Lanto A, Simon B, Valuck R, Sayers J, Lee M (2007) The utility of adding retrospective medication profiling to computerized provider order entry in an ambulatory care population. J Am Med Inform Assoc 14:424–431

    Article  PubMed  Google Scholar 

  23. Doucet J, Chassagne P, Trivalle C, Landrin I, Pauty MD, Kadri N, Ménard JF, Bercoff E (1996) Drug–drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. J Am Geriatr Soc 44:944–948

    PubMed  CAS  Google Scholar 

  24. Lindley CM, Tully MP, Paramsothy V, Tallis RC (1992) Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 21:294–300

    Article  PubMed  CAS  Google Scholar 

  25. Egger SS, Drewe J, Schlienger RG (2003) Potential drug–drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol 58:773–778

    PubMed  Google Scholar 

  26. Bacic-Vrca V, Marusic S, Erdeljic V, Falamic S, Gojo-Tomic N, Rahelic D (2010) The incidence of potential drug–drug interactions in elderly patients with arterial hypertension. Pharm World Sci 32:815–821

    Article  PubMed  CAS  Google Scholar 

  27. Cusack BJ (2004) Pharmacokinetics in older persons. Am J Geriatr Pharmacother 2:274–302

    Article  PubMed  CAS  Google Scholar 

  28. Perazella MA, Mahnensmith RL (1997) Hyperkalemia in the elderly: drugs exacerbate impaired potassium homeostasis. J Gen Intern Med 12:646–656

    Article  PubMed  CAS  Google Scholar 

  29. Uijtendaal EV, Zwart-van Rijkom JE, van Solinge WW, Egberts TC (2011) Frequency of laboratory measurement and hyperkalaemia in hospitalised patients using serum potassium concentration increasing drugs. Eur J Clin Pharmacol 67:933–940

    Article  PubMed  CAS  Google Scholar 

  30. Zwart-van Rijkom JE, Uijtendaal EV, ten Berg MJ, van Solinge WW, Egberts AC (2009) Frequency and nature of drug–drug interactions in a Dutch university hospital. Br J Clin Pharmacol 68:187–193

    Article  PubMed  CAS  Google Scholar 

  31. Iber FL, Murphy PA, Connor ES (1994) Age-related changes in the gastrointestinal system. Effects on drug therapy. Drugs Aging 5:34–48

    Article  PubMed  CAS  Google Scholar 

  32. Madanick RD (2011) Proton pump inhibitor side effects and drug interactions: much ado about nothing? Cleve Clin J Med 78:39–49

    Article  PubMed  Google Scholar 

  33. Sharma VR, Brannon MA, Carloss EA (2004) Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia. South Med J 97:887–889

    Article  PubMed  Google Scholar 

  34. Nutescu E, Chuatrisorn I, Hellenbart E (2011) Drug and dietary interactions of warfarin and novel oral anticoagulants: an update. J Thromb Thrombolysis 31:326–343

    Article  PubMed  CAS  Google Scholar 

  35. Cruciol-Souza JM, Thomson JC (2006) A pharmacoepidemiologic study of drug interactions in a Brazilian teaching hospital. Clinics (Sao Paulo) 61:515–520

    Article  Google Scholar 

  36. O’Neill JL, Remington TL (2003) Drug-induced esophageal injuries and dysphagia. Ann Pharmacother 37:1675–1684

    Article  PubMed  Google Scholar 

  37. Zarowitz BJ (2006) Oral solid potassium chloride and anticholinergic medications: a new drug interaction for an old drug? Geriatr Nurs 27:329–333

    Article  PubMed  Google Scholar 

  38. McMahon FG, Ryan JR, Akdamar K, Ertan A (1984) Effect of potassium chloride supplements on upper gastrointestinal mucosa. Clin Pharmacol Ther 35:852–855

    Article  PubMed  CAS  Google Scholar 

  39. Newton JL (2005) Effect of age-related changes in gastric physiology on tolerability of medications for older people. Drugs Aging 22:655–661

    Article  PubMed  Google Scholar 

  40. Siller-Matula JM, Lang I, Christ G, Jilma B (2008) Calcium-channel blockers reduce the antiplatelet effect of clopidogrel. J Am Coll Cardiol 52:1557–1563

    Article  PubMed  CAS  Google Scholar 

  41. Good CW, Steinhubl SR, Brennan DM, Lincoff AM, Topol EJ, Berger PB (2012) Is there a clinically significant interaction between calcium channel antagonists and clopidogrel?: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. Circ Cardiovasc Interv 5:77–81

    Article  PubMed  CAS  Google Scholar 

  42. Fulda TR, Valuck RJ, Vander Zanden J, Parker S, Byrns PJ (2000) Disagreement among drug compendia on inclusion and ratings of drug–drug interactions. Curr Ther Res 61:540–548

    Article  Google Scholar 

  43. Vitry AI (2007) Comparative assessment of four drug interaction compendia. Br J Clin Pharmacol 63:709–714

    Article  PubMed  CAS  Google Scholar 

  44. Abarca J, Malone DC, Armstrong EP, Grizzle AJ, Hansten PD, Van Bergen RC, Lipton RB (2003) Concordance of severity ratings provided in four drug interaction compendia. J Am Pharm Assoc 44:136–141

    Google Scholar 

  45. Vonbach P, Dubied A, Krähenbühl S, Beer JH (2008) Evaluation of frequently used drug interaction screening programs. Pharm World Sci 30:367–374

    Article  PubMed  Google Scholar 

  46. Barrons R (2004) Evaluation of personal digital assistant software for drug interactions. Am J Health Syst Pharm 61:380–385

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Srecko Marusic.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marusic, S., Bacic-Vrca, V., Obreli Neto, P.R. et al. Actual drug–drug interactions in elderly patients discharged from internal medicine clinic: a prospective observational study. Eur J Clin Pharmacol 69, 1717–1724 (2013). https://doi.org/10.1007/s00228-013-1531-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-013-1531-7

Keywords

Navigation